Quickly and cheaply is the goal of Pathogenica, a start-up that proposes to diagnose diseases using sequencing technology, reports MIT's Technology Review. By the end of 2012, the company hopes to have an FDA-approved product to detect the bacteria behind urinary tract infections, all for $10 a test. "The majority [of current tests] require days to get a result, which is frequently too late," says Columbia University's Ian Lipkin, who is on Pathogenica's board, to Tech Review.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.